Predicting patient response to immunotherapy treatment
Dr. Ofer Sharon discusses a new cancer research platform designed to improve patient outcomes, cut costs, and minimize unnecessary adverse events
Dr. Ofer Sharon discusses a new cancer research platform designed to improve patient outcomes, cut costs, and minimize unnecessary adverse events
One test that can expedite NSCLC treatment selection decisions. The Oncomine Dx Target Test is the first targeted NGS-based in vitro diagnostic test for NSCLC, simultaneously delivering multiple biomarker results from one sample within four days and helping inform treatment decisions.
Find out about the 'revolutionary' technology enabling one lab to provide higher-quality, more timely data for cancer researchers
Watch this on-demand webinar to find out the advantages of immunotyping over immunofixation in detecting M-proteins
Discover how a laboratory in the US is harnessing extrusion- and light-based bioprinters to generate complex, anatomically accurate tissue models
With the help of Bio-Rad’s ultra-sensitive, multiplexed digital PCR system, Biodesix and its research partners are pursuing novel blood tests for the early detection and targeted treatment of lung cancer
Global provider of gene editing and personalized medicine technologies has launched a service for high-throughput gene expression analysis
Sample preparation solutions for unique applications and difficult samples
DNA polymerase included, Complete Kit with optimized enzyme to amplify total RNA in <4 hours, no 3′ bias
Qualitative detection of 15 High-Risk HPV types with simultaneous genotyping of HPV16 and 18 in one tube. Fast. Simple. Accurate.
Qualitative detection and identification of 15 High-Risk HPV genotypes 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, and 68. Fast. Simple. Accurate.
The innovative instrument helps clinical flow cytometry labs automate end-to-end sample preparation
New centrifuge options accommodate speeds up to 110,000 x g and capacities up to six liters
Rapid Selection and Development of GPCR Expressing Mammalian Cell lines using Novel ClonePix Technology
The VENTANA MMR RxDx Panel is the first and only immunohistochemistry-based assay approved to identify endometrial carcinoma patients eligible for treatment with JEMPERLI (dostarlimab).
Explore how the latest advancements and recent regulatory approvals are making truly personalized medicine a reality
Find out how advanced cell counting technology is helping scientists improve the efficiency of bioethanol production
The Thermo Scientific CentriPAK BPC offers sample protection from contamination and enhanced laboratory productivity
From potency testing and profiling to multi-residue and trace-level detection, find out the latest techniques and technologies advancing the field of pesticide and contaminant testing
Forensic scientists at Flinders University present new data that sheds light on 'DNA shedding'
Using the sustainable and non- toxic metals, sodium and iron, researchers have produced an eco-friendly process to develop organic molecules
Researchers have been awarded funding from Cancer Research UK to create the world’s first vaccine to prevent ovarian cancer